Loading...
Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Hepatocellular carcinoma is the most common primary liver cancer and the fourth leading cause of cancer death worldwide. A total of 70–80% of patients are diagnosed at an advanced stage with a dismal prognosis. Sorafenib had been the standard care for almost a decade until 2018 when the Food and Dru...
Saved in:
| Published in: | Medicina (Kaunas) |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6843273/ https://ncbi.nlm.nih.gov/pubmed/31627433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina55100698 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|